Evidence map›Paper›PMID 30394691›Full record

ArticleBirth defects research2018

Population-based surveillance of congenital heart defects among adolescents and adults: surveillance methodology.

Jill Glidewell, Wendy Book, Cheryl Raskind-Hood, Carol Hogue, Julie E Dunn, Michelle Gurvitz, Al Ozonoff, Claire McGarry, Alissa Van Zutphen, George Lui and 2 more

Abstract read
In one paragraph

Article in Birth defects research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Positive Predictive Value ofJournal of the American Heart Association · 2023
    Article
  13. Article
  14. Reproductive Health of Women with Congenital Heart Defects.Journal of women's health (2002) · 2023
    Review
  15. Article
  16. How Well DoJournal of the American Heart Association · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jill GlidewellCenters for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia.ORCID 0000-0003-3905-5458
Wendy BookEmory University, Atlanta, Georgia.
Cheryl Raskind-HoodEmory University, Atlanta, Georgia.
Carol HogueEmory University, Atlanta, Georgia.
Julie E DunnMassachusetts Department of Public Health, Boston, Massachusetts.
Michelle GurvitzBoston Children's Hospital, Boston, Massachusetts.
Al OzonoffBoston Children's Hospital, Boston, Massachusetts.
Claire McGarryNew York State Department of Health, Albany, New York.
Alissa Van ZutphenNew York State Department of Health, Albany, New York.
George LuiStanford University School of Medicine, Stanford, California.
Karrie DowningCenters for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia.ORCID 0000-0002-3063-1781
Tiffany Riehle-ColarussoCenters for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia.

Funding

CDC HHS CDC-RFA-DD12-1207Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundImproved treatment of congenital heart defects (CHDs) has increased survival of persons with CHDs; however, no U.S. population-based systems exist to assess prevalence, healthcare utilization, or longer-term outcomes among adolescents and adults with CHDs.

methodsNovel approaches identified individuals aged 11-64 years who received healthcare with ICD-9-CM codes for CHDs at three sites: Emory University in Atlanta, Georgia (EU), Massachusetts Department of Public Health (MA), New York State Department of Health (NY) between January 1, 2008 (2009 for MA) and December 31, 2010. Case-finding sources included outpatient clinics; Medicaid and other claims data; and hospital inpatient, outpatient, and emergency visit data. Supplemental information came from state vital records (EU, MA), and birth defects registries (EU, NY). Demographics and diagnostic and procedural codes were linked, de-duplicated, and shared in a de-identified dataset. Cases were categorized into one of five mutually exclusive CHD severity groups; non-cardiac comorbidity codes were grouped into broad categories.

results73,112 individuals with CHD codes in healthcare encounters were identified. Primary data source type varied: clinics (EU, NY for adolescents), claims (MA), hospital (NY for adults). There was a high rate of missing data for some variables and data varied in format and quality. Some diagnostic codes had poor specificity for CHD ascertainment.

conclusionsTo our knowledge, this is the first population-based, multi-site CHD surveillance among adolescents and adults in the U.S. Identification of people living with CHDs through healthcare encounters using multiple data sources was feasible, though data quality varied and linkage/de-duplication was labor-intensive.

Indexed as

AdolescentAdultChildCongenital AbnormalitiesDatabases, FactualEpidemiological MonitoringFemaleGeorgiaHeart Defects, CongenitalHospitalsHumansMaleMassachusettsMiddle AgedNew YorkPopulation Surveillancebirth defectsbirth defects registrycongenital heart defectssurveillance

Identifiers

PMID30394691
PMCPMC6701175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.